Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-004510
Filing Date
2014-01-28
Accepted
2014-01-28 17:10:55
Documents
2
Period of Report
2013-11-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v366324_4.html 4  
1 OWNERSHIP DOCUMENT v366324_4.xml 4 20365
2 EXHIBIT 24 v366324_ex24.htm EX-24 9061
  Complete submission text file 0001144204-14-004510.txt   31176
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019
Business Address
Kazam Joshua A (Reporting) CIK: 0001221355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 14553812